A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy
Renal cell carcinoma (RCC) represents 2-3% of all cancers in adults worldwide, and has an annual increase of around 2% in incidence during the past two decades [1]. Improved diagnostics have resulted in the increasing discovery of low stage renal tumors. Involvement of the venous system is a clinical characteristic of advanced RCC, which is observed in 4-10% of all RCC patients [2]. Radical nephrectomy with thrombectomy (RNTE) is the only curative therapeutic modality for these patients [3]. However, despite the aggressive resection was performed, the long-term survival of RCC with tumor thrombus (TT) remains poor compared to localized RCC.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Liangyou Gu, Hongzhao Li, Zihuan Wang, Baojun Wang, Qingbo Huang, Xiangjun Lyu, Dan Shen, Yu Gao, Yang Fan, Xintao Li, Yongpeng Xie, Songliang Du, Kan Liu, Lu Tang, Cheng Peng, Xin Ma, Xu Zhang Tags: Systematic or Meta-analysis Studies Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Study | Thrombosis